Table 1.
Comparison of baseline data
| Factors | Control group (n=40) | Observation group (n=48) | χ2/Z | P |
|---|---|---|---|---|
| Age | ||||
| ≥60 years old | 24 | 20 | 2.933 | 0.086 |
| <60 years old | 16 | 28 | ||
| Sex | ||||
| Male | 22 | 28 | 0.098 | 0.753 |
| Female | 18 | 20 | ||
| Ann Arbor Stage | ||||
| Stage II | 16 | 22 | -0.180 | 0.858 |
| Stage III | 12 | 10 | ||
| Stage IV | 12 | 16 | ||
| B Symptoms | ||||
| Existed | 7 | 10 | 0.155 | 0.693 |
| Non-existed | 33 | 38 | ||
| Pathological type | ||||
| Follicular Lymphoma | 28 | 33 | 0.016 | 0.899 |
| Other | 12 | 15 | ||
| Pretreatment disease state | ||||
| Initial Treatment | 20 | 20 | 0.611 | 0.434 |
| relapsed/refractory | 20 | 28 | ||
| LDH Level | ||||
| Normal | 7 | 5 | 0.929 | 0.335 |
| Above Normal | 33 | 43 |
Lactate dehydrogenase (LDH).